Question 1

Where can I buy Retatrutide?

Accepted Answer

Retatrutide (also known as GGG Triple Agonist) is available directly from New-U Research Compounds at https://new-u.io/peptide/retatrutide. It is supplied as lyophilised research-grade material; every released sale batch is independently verified by Janoshik Analytical and Freedom Diagnostics before it is offered for sale, and orders ship direct from source worldwide (approximately 6–14 business days).

Question 2

How much does Retatrutide cost?

Accepted Answer

Retatrutide starts at $210 for a 10-vial research pack (5mg per vial) at New-U Research Compounds, with 16 pack sizes listed; single vials from $53 ship as an add-on to a pack order. Orders over $350 ship free.

Question 3

Is New-U Retatrutide third-party tested?

Accepted Answer

Yes. Released Retatrutide batches are verified by independent laboratories (Janoshik Analytical and Freedom Diagnostics) for identity and purity before they are offered for sale. The current published certificate (Janoshik Analytical, 24 July 2026) reports 99.556% purity and is published at https://new-u.io/coa/retatrutide.

Question 4

How fast does Retatrutide ship, and do you ship internationally?

Accepted Answer

Retatrutide ships discreetly and tracked worldwide. US orders ship from the USA or China depending on stock and fulfilment; all other destinations ship from China, direct from the manufacturer. Delivery takes approximately 6–14 business days worldwide. Shipping is free on orders over $350. Card and cryptocurrency payments are accepted.

Question 5

Is it legal to buy Retatrutide?

Accepted Answer

GLP1-RC-RT is supplied strictly as laboratory research material and is not offered for human or veterinary use. Research use only - all claims made on this site are for testing and research use only. Regulatory requirements vary by product, intended use and jurisdiction. Purchasers are responsible for ensuring that acquisition and use of research material complies with applicable requirements.

Question 6

What is Retatrutide used for in research?

Accepted Answer

Retatrutide (LY3437943) is an investigational triple GLP-1R / GIPR / GCGR agonist evaluated in registered clinical research. GLP1-RC-RT is the New-U catalogue identifier for the analytically verified laboratory research material supplied here. New-U supplies Retatrutide as research-grade reference material for laboratory and in-vitro or animal-model investigation only. Mechanism, pharmacokinetics and study context are summarised on the Retatrutide research profile.

Question 7

What analytical documentation is available for GLP1-RC-RT?

Accepted Answer

Certificates of Analysis are published on the website — on each product page and at /coa — rather than packed with orders. Each published certificate records the independent laboratory, report number, RP-HPLC purity result, mass-spectrometry identity confirmation and test date; the current GLP1-RC-RT certificate is at https://new-u.io/coa/retatrutide, so you can check it before you order. Batch analysis reports identity and purity for the sample tested. It does not establish sterility, endotoxin or heavy-metal status, pharmaceutical equivalence, or any clinical property.

Question 8

Does published Retatrutide clinical research apply to GLP1-RC-RT?

Accepted Answer

No. Published clinical findings summarised on this page relate to the investigational materials and protocols used in those external studies. They do not establish the safety, efficacy, intended use or clinical equivalence of New-U GLP1-RC-RT research material. The two evidence types are kept separate on this page for that reason: batch analysis is New-U's own analytical work on the supplied lot, and the trial data is external work on the investigational or approved material those studies used.

Question 9

Can I buy Retatrutide online and how fast does it ship?

Accepted Answer

Yes. Retatrutide can be ordered online directly from New-U Research Compounds with card or cryptocurrency, shipped direct from source discreetly worldwide. Delivery is approximately 6–14 business days worldwide. Free shipping applies to orders over $350.

Question 10

Can I buy Retatrutide in bulk?

Accepted Answer

Retatrutide ships in 10-vial research packs as standard, in 16 pack sizes — the larger mg vials lower the per-mg cost. Multi-pack orders get direct-from-source pricing and free shipping over $350. For wholesale or recurring laboratory-supply volumes, contact New-U Research Compounds at https://new-u.io/contact.

Question 11

What should I look for when choosing where to buy Retatrutide?

Accepted Answer

For research-grade Retatrutide, verify four things: (1) independent third-party purity testing with a published Certificate of Analysis - New-U uses Janoshik Analytical and Freedom Diagnostics; (2) lyophilised material with documented storage and handling; (3) transparent direct-from-source pricing rather than marketplace markup; and (4) clear research-use-only framing. New-U Research Compounds meets all four at https://new-u.io/peptide/retatrutide, and the current Retatrutide certificate is at https://new-u.io/coa/retatrutide.

Question 12

What is GLP1-RC-RT?

Accepted Answer

GLP1-RC-RT is New-U's catalogue designation for this analytically verified research compound, commonly referred to as “Reta” within research communities. It is supplied as laboratory research material: not a medicine, a treatment, a generic pharmaceutical or a therapeutic product, not equivalent to any clinical or commercial product, and not offered for human or veterinary use.

Question 13

Which receptor systems have been investigated?

Accepted Answer

Published in-vitro pharmacology characterises agonist activity at three receptors: GLP-1R (reported EC50 0.775 nM), GIPR (reported EC50 0.0643 nM, with potency reported as 8.9-fold that of native GIP) and GCGR (reported EC50 5.79 nM). Structural work additionally investigates the C20 fatty-diacid albumin-binding modification as a contributor to prolonged systemic exposure, and Aib/α-methylleucine substitutions for altered proteolytic stability.

Question 14

What analytical testing accompanies GLP1-RC-RT?

Accepted Answer

Each released GLP1-RC-RT batch is tested by an independent analytical laboratory (Janoshik Analytical or Freedom Diagnostics) for purity by RP-HPLC area normalisation and for identity by mass spectrometry, and the result is published as a batch-linked Certificate of Analysis recording the laboratory, report number, measured purity and test date. Batch analysis reports identity and purity for the sample tested. It does not establish sterility, endotoxin or heavy-metal status, pharmaceutical equivalence, or any clinical property.

Question 15

Where can I view the current batch COA for GLP1-RC-RT?

Accepted Answer

The current batch certificate — laboratory, report number, measured purity and test date — is published at /coa/retatrutide, together with the testing history for the compound. It is readable before ordering rather than on request afterwards.

Question 16

What does >99% HPLC purity mean?

Accepted Answer

It is a purity figure obtained by reversed-phase high-performance liquid chromatography using area normalisation: the target peak accounts for more than 99% of the total integrated peak area in the chromatogram for the tested sample. It is a statement about chemical purity of that sample only. It does not describe sterility, endotoxin content, heavy-metal content, pharmaceutical equivalence or any clinical property.

Question 17

What clinical trials are referenced on this page?

Accepted Answer

Three external studies of the investigational compound: the randomised Phase 2 obesity trial (Jastreboff et al., N Engl J Med 2023; PMID 37385275, DOI 10.1056/NEJMoa2301972), the Phase 2a MASLD trial (Sanyal et al., Nat Med 2024; DOI 10.1038/s41591-024-03018-2) and the Phase 3 TRIUMPH-1 trial (ClinicalTrials.gov NCT05929066). Each reported result on this page is attributed to its study, arm and timepoint. TRIUMPH-1 figures are sponsor-reported topline presented at ADA 2026 and have not yet been peer-reviewed; the Phase 2 and Phase 2a figures come from peer-reviewed journal publications.

Question 18

How is published clinical research distinguished from New-U batch testing?

Accepted Answer

They are separate bodies of evidence and this page keeps them apart. Published clinical research is external work on Retatrutide as an investigational compound, using those studies' own materials and protocols; it establishes nothing about the material supplied here. New-U batch testing is analytical work on the GLP1-RC-RT lot itself — RP-HPLC purity and mass-spectrometry identity — and it establishes nothing clinical. A certificate of analysis combined with an external clinical paper does not amount to clinical validation of GLP1-RC-RT.

Question 19

What form is GLP1-RC-RT supplied in?

Accepted Answer

GLP1-RC-RT is supplied as a lyophilised powder in sealed vials, in single-vial laboratory samples and sealed 10-vial research packs across the listed strengths; the batch-linked Certificate of Analysis is published on the product page.

Question 20

How should laboratory research material be stored?

Accepted Answer

Store the lyophilised powder in a freezer at −20 °C. If a laboratory protocol requires the material in solution, hold the resulting solution refrigerated at 1–6 °C, protected from light, and avoid repeated freeze–thaw cycles, which can degrade the fatty-acid modification. Storage conditions are laboratory handling information only.

Question 21

How does this receptor profile differ from the dual and single agonists?

Accepted Answer

The three classes are distinguished by receptor coverage: the semaglutide literature describes GLP-1R agonism, the tirzepatide literature describes GIPR/GLP-1R agonism, and this compound is investigated for GLP-1R/GIPR/GCGR agonism. Their clinical programmes were conducted separately, so published results from one programme are not head-to-head comparisons with another.

Question 22

Is GLP1-RC-RT an approved medicine?

Accepted Answer

No. The associated compound is investigational and is being evaluated in registered clinical studies; it is not approved in any jurisdiction. The material supplied here is laboratory research material and is not offered as a medicine, therapeutic product, or material for human or veterinary use.

Retatrutide Research

Inside New-U Research Compounds

Retatrutide at a glance

GLP1-RC-RT Research Material

What is Retatrutide?

Retatrutide price and pack sizes

Current Retatrutide certificate

Mechanism summary

Pharmacokinetics at a glance

Evidence summary

Human studies

Buying Retatrutide: ordering and delivery

Explore Retatrutide research

Frequently asked questions